(1 - 28 von 31
)
DKTK partner site Essen/Düsseldorf starts new cooperation with...
www.dkfz.de
Thanks to their particular strength in the biomedical area, they provide numerous project ideas offering very promising approaches for application-oriented drug discovery,” Dr Bert Klebl, Managing Director and CSO of the LDC, comments.
Ten years of substance research - max-planck-innovation.com
www.max-planck-innovation.com
Web · In 2006, Stein-Gerlach and Ullrich consequently joined forces with the present-day CEO and scientific director of the LDC, Bert Klebl, to develop a concept for a new …
Max-Planck’s Lead Discovery Centre forms partnership with InterMed |...
sciencebusiness.net
Bert Klebl, Managing Director and chief scientific officer of LDC, said, “[We] aim to achieve the very highest levels of quality in early drug ...
Nodus Oncology Secures £2.4m ($2.9m) InvestmentGlobeNewswire
www.globenewswire.com
— KHAN Technology Transfer Fund I (KHAN-I) have invested alongside existing investor Cumulus Oncology; Bert Klebl, Managing Director of KHAN-I ... › ...
sortiert nach Relevanz / Datum